NANOSTRING Trademark

Trademark Overview


On Tuesday, March 28, 2017, a trademark application was filed for NANOSTRING with the United States Patent and Trademark Office. The USPTO has given the NANOSTRING trademark a serial number of 87977815. The federal status of this trademark filing is REGISTERED as of Tuesday, August 7, 2018. This trademark is owned by NanoString Technologies, Inc.. The NANOSTRING trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analyte...

Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy n...

Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, meas...
nanostring

General Information


Serial Number87977815
Word MarkNANOSTRING
Filing DateTuesday, March 28, 2017
Status700 - REGISTERED
Status DateTuesday, August 7, 2018
Registration Number5537412
Registration DateTuesday, August 7, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 22, 2017

Trademark Statements


Description of MarkThe mark consists of the word "nanoString" with a line below the word containing circles.
Goods and ServicesDiagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDiagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
Goods and ServicesResearch and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, April 1, 2017
Primary Code001
First Use Anywhere DateWednesday, August 30, 2017
First Use In Commerce DateWednesday, August 30, 2017

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 1, 2017
Primary Code005
First Use Anywhere DateTuesday, January 30, 2018
First Use In Commerce DateTuesday, January 30, 2018

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 1, 2017
Primary Code042
First Use Anywhere DateFriday, May 5, 2017
First Use In Commerce DateFriday, May 5, 2017

Trademark Owner History


Party NameBRUKER SPATIAL BIOLOGY, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBILLERICA, MA 01821

Party NameNanoString Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameNanoString Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameNanoString Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Tuesday, April 4, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 31, 2017NEW APPLICATION ENTERED
Saturday, April 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 20, 2017ASSIGNED TO EXAMINER
Thursday, June 22, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, June 22, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, June 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2017EXAMINERS AMENDMENT E-MAILED
Friday, June 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 30, 2018SOU TEAS EXTENSION RECEIVED
Friday, March 30, 2018SOU EXTENSION 1 FILED
Friday, March 30, 2018SOU EXTENSION 1 GRANTED
Tuesday, April 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 4, 2018TEAS STATEMENT OF USE RECEIVED
Monday, June 4, 2018TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 4, 2018DIVISIONAL REQUEST RECEIVED
Friday, June 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 8, 2018DIVISIONAL PROCESSING COMPLETE
Monday, June 4, 2018USE AMENDMENT FILED
Friday, June 8, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 9, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 29, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 30, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 7, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, March 18, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 7, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 3, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, July 4, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP